Also, mutagenic carcinogens usually produce positive effects in multiple test systems for different genetic end points, particularly gene mutations, and in tests performed in vivo that generally are supported by positive tests in vitro.
Whole mtDNA genome sequencing was undertaken and excluded the possibility of a co-existing mtDNA point mutation, particularly within the mt-tRNAPhe (MTTF) gene.
Accurate identification of point mutation is particularly imperative in the field of biomedical research and clinical diagnosis.
The identification of point mutations is particularly essential in the fields of medical diagnosis and prognosis of many pathogenic and genetic diseases.
At the biochemical level, several studies have reported that LRRK2 disease mutations, particularly mutations in the ROC and COR domains, can affect dimerization16, 17, 40.
Given that follow-up validation of predicted variants by Sanger sequencing is labor-intensive and expensive [ 32], a robust set of criteria for prioritizing putative point mutations for validation, particularly those lacking consensus between prediction algorithms, would be of great benefit.
Considering in vitro attenuation is commonly used to generate MD vaccines, this result prompted further characterization of this mutation, particularly to better understand the potential of point mutations for use in vaccine development.
Two points are particularly important here.
Analysis of the mutations revealed that specific combinations of mutations were particularly important in conferring selective advantage.
While this study identified known mutations and points towards an association between PIK3CA mutations and GBC, the rates of validated mutations in genes such as KRAS, particularly in the intra-hepatic cholangiocarcinomas, were lower than expected given the findings of previous studies[ 2- 6].
